| Atherosclerosis (N = 26) | Cardioembolic (N = 62) | CSVD (N = 75) | Unknown (N = 141) | P-value |
---|
CRP2, mean (SD) | 1.93 (3.29) | 3.06 (3.78) | 1.88 (2.56) | 1.58 (3.71) | 0.032 |
IL-6, mean (SD) | 3.71 (1.95) | 5.70 (2.18) | 3.97 (2.18) | 4.26 (2.39) | 0.038 |
Neopterin, mean (SD) | 16.0 (1.5) | 20.3 (1.7) | 16.0 (1.4) | 16.0 (1.5) | 0.003 |
PAr, mean (SD) | 0.66 (1.77) | 0.73 (1.73) | 0.60 (1.73) | 0.60 (1.56) | 0.087 |
KA, mean (SD) | 59.7 (1.5) | 67.4 (1.4) | 59.7 (1.5) | 57.4 (1.5) | 0.093 |
- 1The category “other determined” was excluded because of low sample size. The analyses were conducted on log-transformed variables, and the values were transformed back after analysis
- 2For CRP: Atherosclerosis: N = 20, cardioembolic: N = 46, CSVD: N = 50, Unknown: N = 100. CSVD=cerebral small vessel disease. CRP = C-reactive protein IL-6 = Interleukin-6. PAr = pyridoxic acid ratio-index = 4-pyridoxic acid:(pyridoxal+pyridoxal 5′-phosphate). KA = kynurenic acid. The analyses were done using a one-way ANOVA